BR9710038A - Novas composições e matrizes radiofarmacêuticas e seus usos. - Google Patents

Novas composições e matrizes radiofarmacêuticas e seus usos.

Info

Publication number
BR9710038A
BR9710038A BR9710038-2A BR9710038A BR9710038A BR 9710038 A BR9710038 A BR 9710038A BR 9710038 A BR9710038 A BR 9710038A BR 9710038 A BR9710038 A BR 9710038A
Authority
BR
Brazil
Prior art keywords
matrices
new
compositions
radiopharmaceutical compositions
radiopharmaceutical
Prior art date
Application number
BR9710038-2A
Other languages
English (en)
Inventor
Jorge Osvaldo Nicolini
Ricardo Julio Ughetti
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/869,460 external-priority patent/US6241962B1/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of BR9710038A publication Critical patent/BR9710038A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"NOVAS COMPOSIçõES E MATRIZES RADIOFARMACêUTICAS E SEUS USOS"<D>. Novas composições radiofarmacêuticas compreendendo, em combinação com um veículo farmaceuticamente aceitável, um sal radioativo de ácido pirofosfórico. Também são proporcionadas novas composições radiofarmacêuticas compreendendo, em combinação com uma ou mais resinas poliméricas, um sal radioativo de ácido pirofosfórico. As combinações e matrizes são apropriadas, inter alia, para o uso nos processos de tratamento envolvendo braquiterapia.
BR9710038-2A 1996-06-24 1997-06-17 Novas composições e matrizes radiofarmacêuticas e seus usos. BR9710038A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66916996A 1996-06-24 1996-06-24
US08/869,460 US6241962B1 (en) 1996-06-24 1997-06-05 Radiopharmaceutical compositions and matrices and uses thereof
PCT/US1997/010585 WO1997049335A1 (en) 1996-06-24 1997-06-17 Novel radiopharmaceutical compositions and matrices and uses thereof

Publications (1)

Publication Number Publication Date
BR9710038A true BR9710038A (pt) 2000-01-11

Family

ID=27100070

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710038-2A BR9710038A (pt) 1996-06-24 1997-06-17 Novas composições e matrizes radiofarmacêuticas e seus usos.

Country Status (13)

Country Link
US (1) US6348184B1 (pt)
EP (1) EP0921756A4 (pt)
JP (1) JP2002514159A (pt)
KR (1) KR20000022136A (pt)
AU (1) AU3492797A (pt)
BR (1) BR9710038A (pt)
CA (1) CA2259343C (pt)
CZ (1) CZ401898A3 (pt)
HR (1) HRP970345A2 (pt)
IL (1) IL127427A (pt)
PL (1) PL330820A1 (pt)
TR (1) TR199802686T2 (pt)
WO (1) WO1997049335A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299175B1 (it) * 1998-05-11 2000-02-29 Enea Ente Nuove Tec Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
GB9915714D0 (en) 1999-07-05 1999-09-08 Nycomed Amersham Plc Products and methods
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2006036269A2 (en) * 2004-09-24 2006-04-06 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
NL2009688C2 (en) * 2012-10-24 2014-04-29 Nucletron Operations Bv A settable radioactive gel, a method of manufacturing a settable radioactive gel, a device for manufacturing a settable radioactive gel.
CN105263477B (zh) 2013-03-13 2019-01-15 生物领域医疗公司 用于放射性同位素结合微粒的组合物和相关方法
US10363324B2 (en) 2013-11-04 2019-07-30 The South African Nuclear Energy Corporation Limited Pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323055A (en) 1980-04-08 1982-04-06 Minnesota Mining And Manufacturing Company Radioactive iodine seed
US4533541A (en) * 1983-08-25 1985-08-06 The United States Of America As Represented By The United States Department Of Energy Tin-117m-labeled stannic (Sn4+) chelates
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4706652A (en) 1985-12-30 1987-11-17 Henry Ford Hospital Temporary radiation therapy
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
US4994013A (en) 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5282781A (en) 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US6241962B1 (en) * 1996-06-24 2001-06-05 Dupont Pharmaceuticals Company Radiopharmaceutical compositions and matrices and uses thereof

Also Published As

Publication number Publication date
IL127427A0 (en) 1999-10-28
PL330820A1 (en) 1999-06-07
CA2259343C (en) 2002-12-03
TR199802686T2 (xx) 1999-04-21
IL127427A (en) 2002-11-10
EP0921756A4 (en) 2003-05-21
US6348184B1 (en) 2002-02-19
CA2259343A1 (en) 1997-12-31
KR20000022136A (ko) 2000-04-25
JP2002514159A (ja) 2002-05-14
WO1997049335A1 (en) 1997-12-31
AU3492797A (en) 1998-01-14
CZ401898A3 (cs) 1999-07-14
HRP970345A2 (en) 1998-04-30
EP0921756A1 (en) 1999-06-16

Similar Documents

Publication Publication Date Title
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
ES8802045A1 (es) Procedimiento para la produccion de tiazoles
EP1820862A3 (en) Medical preparations for the treatment of alpha-galactosidase a deficiency
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
PT735890E (pt) Misturas de 2&#39;,3&#39;-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
IL140684A0 (en) Medicine nitrate salts
BR9710038A (pt) Novas composições e matrizes radiofarmacêuticas e seus usos.
DE3267295D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
EP0268135A3 (en) Coccidiocidal agents
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
DE3674971D1 (en) P-acylaminobenzamide.
EP0255141A3 (en) Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere
SE8500822L (sv) Diazepinoindoler, deras framstellning samt farmaceutiska kompositioner innehallande desamma
ES8800597A1 (es) Procedimiento para la preparacion de una composicion farmaceutica a base de 3-aminopropoxiindoles
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
IT8420529A0 (it) N-acetil-s-acil-cisteina adattivita&#39; terapeutica, procedimento per loro preparazione e loro uso in terapia.
ATE47399T1 (de) Carboxyalkyldipeptide, deren herstellung und deren pharmazeutische zusammensetzungen.
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
AU589684B2 (en) Arylmethylazoles and their salts, processes for their preparation, agents which contain these compounds, and their use.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A , 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.